A is the answer and the winner is Essein.
Details Below:
When heparin is administered by intravenous or subcutaneous injection, it has
a rapid onset of action and an average halflife of 1.5 h. There is variability
in halflife ranging between 1 to 6 h depending on a number of factors such
as renal impairment and liver disease. It carries a risk of bleeding and the
patient should be monitored for signs of haemorrhage.
A is the answer and the winner is Essein.
Details Below:
When heparin is administered by intravenous or subcutaneous injection, it has
a rapid onset of action and an average halflife of 1.5 h. There is variability
in halflife ranging between 1 to 6 h depending on a number of factors such
as renal impairment and liver disease. It carries a risk of bleeding and the
patient should be monitored for signs of haemorrhage.
C
E
C
A
D